Antibody fragment discovery could lead to much-needed treatment for light chain amyloidosis

FHS
July 10, 2024
7:14 pm

In people with a rare condition called light chain amyloidosis, light chain proteins-;which are a component of antibodies-;mutate and build up in different organs.

Exclusive: Flagship names two CEO-partners to lead Valo Health, Apriori Bio

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 14, 2024

Opinion | Growing Evidence of ‘Harm’ From Social Media, Says Surgeon General

Emily Hutto is an Associate Video Producer & Editor for MedPage Today. She is based in Manhattan. In this exclusive video interview, MedPage Today‘s editor-in-chief

July 18, 2024

High NfL Levels Predict Greater MS Disability Within 2 Years

Multiple sclerosis patients whose blood tests revealed elevated levels of neurofilament light chain (NfL), a biomarker of axonal damage, had worsening disability 1 to 2

November 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.